For instance, Meng et al. constructs the P-glycoprotein (Pgp) siRNA-loaded nanoparticles and reverses doxorubicin resistance in breast cancer, providing a theoretical basis for ncRNA-based therapies in overcoming sorafenib resistance (101). This evidence concerns the gene PGP and breast carcinoma.